5 Best Undervalued UK Stocks To Buy Now

4. Bicycle Therapeutics plc (NASDAQ:BCYC)

Latest Share Price Upside: 220%

Number of Hedge Fund Investors In Q2 2023: 24

Bicycle Therapeutics plc (NASDAQ:BCYC) is a healthcare company that develops treatments for complications from diabetes, immune system disorders, and other ailments. The firm scored a win in October 2023 when its bladder cancer treatment was selected by the FDA for faster development times to help early patients.

During 2023’s June quarter, 24 out of the 910 hedge funds tracked by Insider Monkey had held a stake in the firm. Bicycle Therapeutics plc (NASDAQ:BCYC)’s biggest hedge fund shareholder is David Kroin’s Deep Track Capital as it owns 2.8 million shares that are worth $71.9 million.

Follow Bicycle Therapeutics Plc (NASDAQ:BCYC)